FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elmostafa Bahraoui

Research Profile

Chemicals & Drugs

Anatomy

Cell Line

Physiology

Antibody Specificity

Co-author Network

Publications

TOP 3
Nawal Ben Haij; Olfa Mzoughi; Rémi Planès; Elmostafa Bahraoui
Cationic nanoglycolipidic particles as vector and adjuvant for the study of the immunogenicity of SIV Nef protein.
xavier contreras; Fabrice Gaston; Olfa Mzoughi; Matija B Peterlin; Elmostafa Bahraoui
Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages.
Olfa Mzoughi; Fabrice Gaston; Giovana C Granados; Faouzi Lakhdar-Ghazal; Ernest Giralt; Elmostafa Bahraoui
Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elmostafa Bahraoui (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Nawal Ben Haij; Olfa Mzoughi; Rémi Planès; Elmostafa Bahraoui
Cationic nanoglycolipidic particles as vector and adjuvant for the study of the immunogenicity of SIV Nef protein.
International journal of pharmaceutics 2012;423(1):116-23.
2012: xavier contreras; Fabrice Gaston; Olfa Mzoughi; Matija B Peterlin; Elmostafa Bahraoui
Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages.
Retrovirology 2012;9():37.
2010: Olfa Mzoughi; Fabrice Gaston; Giovana C Granados; Faouzi Lakhdar-Ghazal; Ernest Giralt; Elmostafa Bahraoui
Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.
ChemMedChem 2010;5(11):1907-18.
2010: Fabrice Gaston; Tahar Babas; Faouzi Lakhdar-Ghazal; Elmostafa Bahraoui
Structure-antigenicity of the V3 region of SIVmac envelope glycoprotein.
Journal of peptide science : an official publication of the European Peptide Society 2010;16(1):48-57.
2009: Fabrice Gaston; Giovana C Granados; Sergio Madurga; Francesc Rabanal; Faouzi Lakhdar-Ghazal; Ernest Giralt; Elmostafa Bahraoui
Development and characterization of peptidic fusion inhibitors derived from HIV-1 gp41 with partial D-amino acid substitutions.
ChemMedChem 2009;4(4):570-81.
2008: Kaoutar Leghmari; Yamina Bennasser; Elmostafa Bahraoui
HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways.
European journal of cell biology 2008;87(12):947-62.
2008: Kaoutar Leghmari; Yamina Bennasser; Jean Tkaczuk; Elmostafa Bahraoui
HIV-1 Tat protein induces IL-10 production by an alternative TNF-alpha-independent pathway in monocytes: role of PKC-delta and p38 MAP kinase.
Cellular immunology 2008;253(1-2):45-53.
2008: Kaoutar Leghmari; xavier contreras; Corinne Moureau; Elmostafa Bahraoui
HIV-1 Tat protein induces TNF-alpha and IL-10 production by human macrophages: differential implication of PKC-betaII and -delta isozymes and MAP kinases ERK1/2 and p38.
Cellular immunology 2008;254(1):46-55.
2005: xavier contreras; Yamina Bennasser; Nathalie Chazal; Marc Moreau; Catherine Leclerc; Jean Tkaczuk; Elmostafa Bahraoui
Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production.
Virology 2005;332(1):316-28.
2004: xavier contreras; Yamina Bennasser; Elmostafa Bahraoui
IL-10 production induced by HIV-1 Tat stimulation of human monocytes is dependent on the activation of PKC beta(II) and delta isozymes.
Microbes and infection / Institut Pasteur 2004;6(13):1182-90.
2003: xavier contreras; Yamina Bennasser; Nathalie Chazal; Elmostafa Bahraoui
[HIV-1 Tat induces TNF-alpha production by human monocytes: involvement of calcium and PKC pathways].
Journal de la Société de biologie 2003;197(3):267-75.
2002: Yamina Bennasser; Abdallah Badou; Jean Tkaczuk; Elmostafa Bahraoui
Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha.
Virology 2002;303(1):174-80.
2002: Bouchaib Bahbouhi; Nathalie Chazal; Nabil Georges Seidah; Cristina Chiva; Marcelo Kogan; Fernando Albericio; Ernest Giralt; Elmostafa Bahraoui
Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.
The Biochemical journal 2002;366(Pt 3):863-72.
2002: Nicolas Cazeaux; Yamina Bennasser; Pierre-Louis Vidal; Zhenlin Li; D Paulin; Elmostafa Bahraoui
Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter.
Vaccine 2002;20(27-28):3322-31.
2002: Yamina Bennasser; Elmostafa Bahraoui
HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(6):546-54.
2002: Corinne Moureau; Pierre-Louis Vidal; Yamina Bennasser; Marinette Moynier; Yvan Nicaise; Muriel Aussillous; Sophie Barthelemy; Luc Montagnier; Elmostafa Bahraoui
Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
Molecular immunology 2002;38(8):607-18.
2001: Bouchaib Bahbouhi; Nabil Georges Seidah; Elmostafa Bahraoui
Replication of HIV-1 viruses in the presence of the Portland alpha1-antitrypsin variant (alpha1-PDX) inhibitor.
The Biochemical journal 2001;360(Pt 1):127-34.
2001: Bouchaib Bahbouhi; M Bendjennat; Cristina Chiva; M Kogan; Fernando Albericio; Ernest Giralt; Nabil Georges Seidah; Elmostafa Bahraoui
Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
Microbes and infection / Institut Pasteur 2001;3(13):1073-84.
2001: M Bendjennat; Bouchaib Bahbouhi; Elmostafa Bahraoui
Purification and characterization of a Ca2+-independent endoprotease activity from peripheral blood lymphocytes: involvement in HIV-1 gp160 maturation.
Biochemistry 2001;40(15):4800-10.
2001: Yamina Bennasser; B Yamina; xavier contreras; C Xavier; Marc Moreau; M Marc; C Le Clerc; L Catherine; Abdallah Badou; B Abdallah; Elmostafa Bahraoui
[HIV-1 Tat protein induces IL-10 production by human monocytes: implications of the PKC and calcium pathway].
Journal de la Société de biologie 2001;195(3):319-26.
2000: Bouchaib Bahbouhi; M Bendjennat; D Guétard; Nabil Georges Seidah; Elmostafa Bahraoui
Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication.
The Biochemical journal 2000;352 Pt 1():91-8.
2000: Abdallah Badou; Yamina Bennasser; Marc Moreau; Catherine Leclerc; Monsef Benkirane; Elmostafa Bahraoui
Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway.
Journal of virology 2000;74(22):10551-62.
1999: Corinne Moureau; Marinette Moynier; V Kavsan; Luc Montagnier; Elmostafa Bahraoui
Specificity of anti-Nef antibodies produced in mice immunized with DNA encoding the HIV-1 nef gene product.
Vaccine 1999;18(3-4):333-41.
1999: M Bendjennat; Alain Blanchard; M Loutfi; Luc Montagnier; Elmostafa Bahraoui
Role of Mycoplasma penetrans endonuclease P40 as a potential pathogenic determinant.
Infection and immunity 1999;67(9):4456-62.
1999: Olivier Neyrolles; J P Eliane; Stéphane Ferris; R A da Cunha; Marie-Christine Prevost; Elmostafa Bahraoui; Alain Blanchard
Antigenic characterization and cytolocalization of P35, the major Mycoplasma penetrans antigen.
Microbiology (Reading, England) 1999;145 ( Pt 2)():343-55.
1998: B Belhadj Jrad; Stéphane Massou; Jerzy Czaplicki; Corinne Moureau; Marinette Moynier; P Fourquet; Alain Milon; J C Mazié; Elmostafa Bahraoui
Structure/antigenicity relationship of cyclic and linear peptides mimicking the V3 loop of HIV2 envelope glycoprotein.
Research in virology 1998;149(6):363-73.
1998: Marinette Moynier; V Kavsan; Celine Gales; Luc Montagnier; Elmostafa Bahraoui
Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein.
Vaccine 1998;16(16):1523-30.
1998: O Grau; Philippe Tuppin; B Slizewicz; V Launay; C Goujard; Elmostafa Bahraoui; Jean-François Delfraissy; Luc Montagnier
A longitudinal study of seroreactivity against Mycoplasma penetrans in HIV-infected homosexual men: association with disease progression.
AIDS research and human retroviruses 1998;14(8):661-7.
1998: B Belhadj Jrad; Elmostafa Bahraoui
Antigenicity of linear and cyclic peptides mimicking the disulfide loops in HIV-2 envelope glycoprotein: synthesis, reoxidation and purification.
The journal of peptide research : official journal of the American Peptide Society 1998;51(5):370-85.
1998: Sophie Barthelemy; Laurent Vergnes; Marinette Moynier; D Guyot; Serge Labidalle; Elmostafa Bahraoui
Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat.
Research in virology 1998;149(1):43-52.
1997: B B Jrad; Elmostafa Bahraoui
Linear and cyclic peptides mimicking the disulfide loops in HIV-2 envelope glycoprotein induced antibodies with different specificity.
Molecular immunology 1997;34(16-17):1177-89.
1997: T Babas; R Le Grand; D Dormont; Elmostafa Bahraoui
Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
AIDS research and human retroviruses 1997;13(13):1109-19.
1997: M Bendjennat; Alain Blanchard; M Loutfi; Luc Montagnier; Elmostafa Bahraoui
Purification and characterization of Mycoplasma penetrans Ca2+/Mg2+-dependent endonuclease.
Journal of bacteriology 1997;179(7):2210-20.
1997: Elias Stefas; Marcel Rucheton; Hubert Graafland; M Moynier; C Sompeyrac; Elmostafa Bahraoui; Francisco Veas
Human plasmatic apolipoprotein H binds human immunodeficiency virus type 1 and type 2 proteins.
AIDS research and human retroviruses 1997;13(1):97-104.
1995: T Babas; B Belhadj-Jrad; R Le Grand; D Dormont; Luc Montagnier; Elmostafa Bahraoui
Specificity and neutralizing capacity of three monoclonal antibodies produced against the envelope glycoprotein of simian immunodeficiency virus isolate 251.
Virology 1995;211(1):339-44.
1994: Maxime Moulard; T Achstetter; M P Kieny; Luc Montagnier; Elmostafa Bahraoui
Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
European journal of biochemistry / FEBS 1994;225(2):565-72.
1994: T N Tham; Stéphane Ferris; Elmostafa Bahraoui; S Canarelli; Luc Montagnier; Alain Blanchard
Identification of an adhesin-like gene of Mycoplasma pirum isolated from AIDS patients.
Annals of the New York Academy of Sciences 1994;730():279-82.
1994: E Vives; P Charneau; Jurphaas van Rietschoten; Hervé Rochat; Elmostafa Bahraoui
Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides.
Journal of virology 1994;68(5):3343-53.
1994: T Babas; S Benichou; D Guetard; Luc Montagnier; Elmostafa Bahraoui
Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2.
Molecular immunology 1994;31(5):361-9.
1994: Maxime Moulard; Luc Montagnier; Elmostafa Bahraoui
Effects of calcium ions on proteolytic processing of HIV-1 gp160 precursor and on cell fusion.
FEBS letters 1994;338(3):281-4.
1994: T N Tham; Stéphane Ferris; Elmostafa Bahraoui; S Canarelli; Luc Montagnier; Alain Blanchard
Molecular characterization of the P1-like adhesin gene from Mycoplasma pirum.
Journal of bacteriology 1994;176(3):781-8.
1994: Maxime Moulard; T Achstetter; Y Ikehara; Elmostafa Bahraoui
T4-lymphocyte endoprotease responsible for the proteolytic processing of HIV-1 gp160, like Kex2p endoprotease, is a calcium-dependent enzyme.
Biochimie 1994;76(3-4):251-6.
1993: Kamel Mabrouk; Maxime Moulard; J C Gluckman; R Romi; Hervé Rochat; Jurphaas van Rietschoten; Elmostafa Bahraoui
Evaluation of structure-antigenicity relationship of peptides from human immunodeficiency virus type 1 (HIV-1) p18 protein by circular dichroism.
Molecular immunology 1993;30(5):503-12.
1993: Abdelaziz Benjouad; Jean Claude Gluckman; Luc Montagnier; Elmostafa Bahraoui
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
Journal of virology 1993;67(3):1693-7.
1993: Abdelaziz Benjouad; T Babas; Luc Montagnier; Elmostafa Bahraoui
N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor.
Biochemical and biophysical research communications 1993;190(2):311-9.
1992: Kamel Mabrouk; Abdelaziz Benjouad; J C Gluckman; Hervé Rochat; Jurphaas van Rietschoten; Elmostafa Bahraoui
Specificity of anti-P25 antibodies produced against whole HIV-1 particles or soluble forms of the protein.
Molecular immunology 1992;29(11):1309-18.
1992: Elmostafa Bahraoui; Abdelaziz Benjouad; D Guetard; H Kolbe; J C Gluckman; Luc Montagnier
Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
AIDS research and human retroviruses 1992;8(5):565-73.
1992: Abdelaziz Benjouad; Jean Claude Gluckman; Hervé Rochat; Luc Montagnier; Elmostafa Bahraoui
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.
Journal of virology 1992;66(4):2473-83.
1991: B Clerget-Raslain; Abdelaziz Benjouad; Jurphaas van Rietschoten; Luc Montagnier; Hervé Rochat; Elmostafa Bahraoui
Specificity of anti-peptide antibodies elicited against synthetic peptides mimicking conserved regions of HIV1 envelope glycoprotein.
Research in virology 1991;142(6):423-38.
1991: Gilles Dadaglio; A Leroux; Pierre Langlade-Demoyen; Elmostafa Bahraoui; François Traincard; R Fisher; F Plata
Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(7):2302-9.
1991: Liliane Gattegno; H Sadeghi; Line Saffar; D Bladier; B Clerget-Raslain; Jean Claude Gluckman; Elmostafa Bahraoui
N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1.
Carbohydrate research 1991;213():79-93.
1991: T Jouault; F Chapuis; Elmostafa Bahraoui; Jean Claude Gluckman
Infection of monocytic cells by HIV1: combined role of FcR and CD4.
Research in virology 1991;142(2-3):183-8.
1991: Jean-Marc Sabatier; E Vives; Kamel Mabrouk; Abdelaziz Benjouad; Hervé Rochat; A Duval; Bernard Hue; Elmostafa Bahraoui
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.
Journal of virology 1991;65(2):961-7.
1991: Jean Claude Gluckman; Micael Yagello; Elmostafa Bahraoui; M Girard
Current approaches to vaccination against human immunodeficiency viruses.
Allergologia et immunopathologia 1991;19(1):11-3.
1990: Elmostafa Bahraoui; Micael Yagello; J N Billaud; Jean-Marc Sabatier; B Guy; E Muchmore; M Girard; Jean Claude Gluckman
Immunogenicity of the human immunodeficiency virus (HIV) recombinant nef gene product. Mapping of T-cell and B-cell epitopes in immunized chimpanzees.
AIDS research and human retroviruses 1990;6(9):1087-98.
1990: Elmostafa Bahraoui; Abdelaziz Benjouad; Jean-Marc Sabatier; J P Allain; Y Laurian; Luc Montagnier; J C Gluckman
Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection.
Blood 1990;76(1):257-64.
1990: Emmanuel Fenouillet; Jean Claude Gluckman; Elmostafa Bahraoui
Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.
Journal of virology 1990;64(6):2841-8.
1990: alain charbit; A Molla; J Ronco; Jean-Marie Clément; V Favier; Elmostafa Bahraoui; Luc Montagnier; A Leguern; Maurice Hofnung
Immunogenicity and antigenicity of conserved peptides from the envelope of HIV-1 expressed at the surface of recombinant bacteria.
AIDS (London, England) 1990;4(6):545-51.
1990: Jean-Marc Sabatier; G Fontan; E Loret; Kamel Mabrouk; Hervé Rochat; Jean Claude Gluckman; Luc Montagnier; Claude Granier; Elmostafa Bahraoui; Jurphaas van Rietschoten
Large fragments of nef-protein and gp110 envelope glycoprotein from HIV-1. Synthesis, CD analysis and immunoreactivity.
International journal of peptide and protein research 1990;35(1):63-72.
1990: S Prigent; D Goossens; B Clerget-Raslain; Elmostafa Bahraoui; M Roussel; G Tsikas; A Laurent; Luc Montagnier; C Salmon; Jean Claude Gluckman
Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1.
AIDS (London, England) 1990;4(1):11-9.
1990: Luc Montagnier; D Berneman; Denise Guétard; Alain Blanchard; S Chamaret; V Rame; Jurphaas van Rietschoten; Kamel Mabrouk; Elmostafa Bahraoui
[Infectivity inhibition of HIV prototype strains by antibodies directed against a peptide sequence of mycoplasma].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1990;311(12):425-30.
1990: M L Defendini; Elmostafa Bahraoui; CATHERINE LABBE-JULLIE; A Regnier-Vigouroux; Mohamed El Ayeb; Jurphaas van Rietschoten; Hervé Rochat; Claude Granier
Identification of antigenic residues on apamin recognized by polyclonal antibodies.
Molecular immunology 1990;27(1):37-44.
1989: Elmostafa Bahraoui; B Clerget-Raslain; Claude Granier; Jurphaas van Rietschoten; Jean-Marc Sabatier; C Labbé-Julie; B Ceard; Hervé Rochat; Jean Claude Gluckman; Luc Montagnier
Accessibility of the highly conserved amino- and carboxy-terminal regions from HIV-1 external envelope glycoproteins.
AIDS research and human retroviruses 1989;5(4):451-63.
1989: C Granier; J Novotny; J C Fontecilla-Camps; P Fourquet; M el Ayeb; Elmostafa Bahraoui
The antigenic structure of a scorpion toxin.
Molecular immunology 1989;26(6):503-13.
1989: Jean-Marc Sabatier; B Clerget-Raslain; G Fontan; Emmanuel Fenouillet; Hervé Rochat; Claude Granier; Jean Claude Gluckman; Jurphaas van Rietschoten; Luc Montagnier; Elmostafa Bahraoui
Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients.
AIDS (London, England) 1989;3(4):215-20.
1989: Emmanuel Fenouillet; B Clerget-Raslain; Jean Claude Gluckman; Denise Guétard; Luc Montagnier; Elmostafa Bahraoui
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
The Journal of experimental medicine 1989;169(3):807-22.
1989: T Jouault; F Chapuis; R Olivier; C Parravicini; Elmostafa Bahraoui; Jean Claude Gluckman
HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors.
AIDS (London, England) 1989;3(3):125-33.
1989: Elmostafa Bahraoui; Mohamed El Ayeb; Claude Granier; L Beress; H Rochat
Specificity of antibodies to sea anemone toxin III and immunogenicity of the pharmacological site of anemone and scorpion toxins.
European journal of biochemistry / FEBS 1989;180(1):55-60.
1988: Marie-Louise Michel; M Mancini; E Sobczak; V Favier; D Guetard; Elmostafa Bahraoui; Pierre Tiollais
Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(21):7957-61.
1988: P Fourquet; Elmostafa Bahraoui; J C Fontecilla-Camps; Jurphaas van Rietschoten; H Rochat; C Granier
Immunochemistry of scorpion toxins. Synthesis and antigenic properties of a model of a loop region specific to alpha-toxins.
International journal of peptide and protein research 1988;32(2):81-8.
1988: Elmostafa Bahraoui; J Pichon; Jean-Marc MULLER; Hervé Darbon; M Elayeb; C Granier; Jacques Marvaldi; Hervé Rochat
Monoclonal antibodies to scorpion toxins. Characterization and molecular mechanisms of neutralization.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(1):214-20.
1988: Elmostafa Bahraoui; B Clerget-Raslain; F Chapuis; R Olivier; C Parravicini; Micael Yagello; Luc Montagnier; Jean Claude Gluckman
A molecular mechanism of inhibition of HIV-1 binding to CD4+ cells by monoclonal antibodies to gp110.
AIDS (London, England) 1988;2(3):165-9.
1987: Elmostafa Bahraoui; M el Ayeb; C Granier; H Rochat
Immunochemistry of scorpion toxins. Immunogenicity of peptide 19-28 a model of an accessible and relatively rigid region.
European journal of biochemistry / FEBS 1987;167(2):371-5.
1987: Elmostafa Bahraoui; M el Ayeb; C Granier; J Van Rietschoten; H Rochat
Antigenicity of peptide 19-28 of toxin II from the scorpion Androctonus australis as measured by different solid-phase tests and characterization of specific antibodies purified by immunoaffinity on the peptide or the toxin.
Toxicon : official journal of the International Society on Toxinology 1987;25(9):957-64.
1986: Mohamed El Ayeb; Elmostafa Bahraoui; Claude Granier; L Beress; H Rochat
Immunochemistry of sea anemone toxins: structure-antigenicity relationships and toxin-receptor interactions probed by antibodies specific for one antigenic region.
Biochemistry 1986;25(22):6755-61.
1986: Mohamed El Ayeb; Elmostafa Bahraoui; Claude Granier; H Rochat
Use of antibodies specific to defined regions of scorpion alpha-toxin to study its interaction with its receptor site on the sodium channel.
Biochemistry 1986;25(21):6671-8.
1986: Elmostafa Bahraoui; Claude Granier; Jurphaas van Rietschoten; H Rochat; Mohamed El Ayeb
Specificity and neutralizing capacity of antibodies elicited by a synthetic peptide of scorpion toxin.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(9):3371-7.
1986: Elmostafa Bahraoui; M el Ayeb; J Van Rietschoten; H Rochat; C Granier
Immunochemistry of scorpion alpha-toxins: study with synthetic peptides of the antigenicity of four regions of toxin II of Androctonus australis Hector.
Molecular immunology 1986;23(4):357-66.
1986: Mohamed El Ayeb; Hervé Darbon; Elmostafa Bahraoui; O Vargas; H Rochat
Differential effects of defined chemical modifications on antigenic and pharmacological activities of scorpion alpha and beta toxins.
European journal of biochemistry / FEBS 1986;155(2):289-94.
1984: Mohamed El Ayeb; Elmostafa Bahraoui; Claude Granier; P Delori; Jurphaas van Rietschoten; Hervé Rochat
Immunochemistry of scorpion alpha-toxins: purification and characterization of two functionally independent IgG populations raised against toxin II of Androctonus australis Hector.
Molecular immunology 1984;21(3):223-32.
1984: C Granier; Elmostafa Bahraoui; J Van Rietschoten; H Rochat; M El Ayeb
Synthesis and immunological characterization of two peptides which are models for two of the four major antigenic sites of a scorpion toxin.
International journal of peptide and protein research 1984;23(2):187-97.